TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).

Roberto Pili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.